NJBIZ4d
Sun Pharma expanding Princeton HQ with $5.2M in tax credits
The New Jersey Economic Development Authority board March 12 approved $5.24 million in tax credits under the Emerge Program ...
Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million
Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...
Sun Pharma To Open New Headquarters In Princeton Area: NJEDA
Board approved tax credits under the Emerge Program to support Sun Pharmaceutical Industries Inc.’s plan to open a new head ...
New Jersey Business Magazine3d
Emerge Program Secures Sun Pharma’s Presence in NJ
The NJEDA Board approved tax credits under the Emerge Program to support Sun Pharmaceutical Industries Inc.’s plan to open a ...
Sun Pharmaceutical Industries advances Monday, outperforms competitors
Sun Pharmaceutical Industries Ltd. closed 12.97% below its 52-week high of 1,960.20 rupees, which the company achieved on ...
FiercePharma7d
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...
Pharm Exec8d
Sun Pharma Acquires Checkpoint Therapeutics for $355 Million
Sun Pharma’s acquisition of Checkpoint Therapeutics includes Unloxcyt, an FDA-approved anti-PD-L1 therapy for metastatic and locally advanced cutaneous squamous cell carcinoma. Sun Pharma announced ...